Yes, I'll be rewarded with a decent amount of iTech shares out of this deal and will hold them and see where iTech takes this.
lol ... yeah... I'm kinda dug in here and have no intention of selling out. I like their strategy going into Deep Tech and they seem to be assembling an amazing team that will drive value I think in the technology they are developing. Time will tell of course but Management, Market and Product has ticked all my boxes and now it's a matter of patience and following this through. I'm in a comfortable position but really looking forward to Archer entering the ASX Tech index - should get real interesting then !
I've researched Mohammad and Martin's achievements extensively and I feel they have what it takes to get these Technologies across the line. Now with the assembled Bio Tech team it's another potential avenue for income generation later after commercialization. There's always a risk, but one well worth taking holding a position here. This to me is a truly amazing story unfolding how a small Aussie company is developing something so disruptive and game changing and yet don't have the big budgets of the big tech players but it will be something they would so desire to have. Not there yet, but gets more exciting as each milestone is hit!
As we've witnessed, stocks like Archer with such disruptive Technologies and high risk will always attract attention and debate, but keeping the eye on the prize and not be distracted by events will prove to be the best way to counter critics.
Looking forward the seeing out 2021 on a high.
Always appreciate your posts and feedback SW
Cheers
- Forums
- ASX - By Stock
- Ann: Update on iTech transaction
AXE
archer materials limited
Add to My Watchlist
0.00%
!
23.0¢

Yes, I'll be rewarded with a decent amount of iTech shares out...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.61M |
Open | High | Low | Value | Volume |
22.5¢ | 24.0¢ | 22.5¢ | $89.25K | 387.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 104441 | 23.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.5¢ | 56023 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 104441 | 0.230 |
8 | 182195 | 0.225 |
11 | 234057 | 0.220 |
7 | 58193 | 0.215 |
8 | 164657 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.235 | 4141 | 1 |
0.240 | 101099 | 4 |
0.245 | 7000 | 1 |
0.250 | 76000 | 3 |
0.255 | 129000 | 3 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AXE (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online